Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03242850 · ClinicalTrials.gov registry record · NA

Assuring Patient-centered Literacy Promotion for Underserved Children Study

A NA study of Literacy, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT03242850: Completed NA study of Literacy, sponsored by Rutgers, The State University of New Jersey.

NCT03242850 is a NA study of Literacy that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 160 participants, above the 112-participant average among 12 other Literacy trials with a reported enrollment target (43% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03242850, a NA study of Literacy, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

This study tests whether an enhanced primary cared based literacy promotion intervention consisting of a video and text message will increase shared reading occurrences between parents and children compared to the standard version.

Primary Outcome

Parents will report reading occurrences in a 1 week period including a 24-hour recall.

Conditions Studied

Interventions

  • BEHAVIORAL Intervention Group

Study Locations (1)

New Jersey

  • Eric B. Chandler Health Center - New Brunswick

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2018-01-24
Est. Completion 2019-08-24
Phase NA

What the finished NCT03242850 record still lists

NCT03242850 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, above the 112-participant average among 12 other Literacy trials with a reported enrollment target (43% higher).

The record links to 1 condition, with Literacy appearing as the primary indexed condition, and to 1 intervention - of which Intervention Group is the first listed.

NCT03242850 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT03242850 about?

NCT03242850 is a clinical study titled "Assuring Patient-centered Literacy Promotion for Underserved Children Study". This study tests whether an enhanced primary cared based literacy promotion intervention consisting of a video and text message will increase shared reading occurrences between parents and children compared to the standard version.

What is the current status of trial NCT03242850?

This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2018-01-24. Estimated completion is 2019-08-24.

What conditions does trial NCT03242850 study?

This clinical trial studies the following conditions: Literacy.

What interventions are being tested in trial NCT03242850?

The interventions under investigation include: Intervention Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT03242850?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03242850 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Literacy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03242850's enrollment target sits among peer trials

160 4th of 12 higher than 9 of 12 other Literacy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Literacy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00932139 · 160 participants · NA

    Effect of Electro-Acupuncture on Blood Pressure

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03242850, the US trial registry maintained by the National Library of Medicine. NCT03242850 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.